Serum Institute to begin trials of Oxford’s Covid-19 vaccine by August-end
4 years, 5 months ago

Serum Institute to begin trials of Oxford’s Covid-19 vaccine by August-end

Live Mint  

Mumbai: Serum Institute of India on Tuesday said it will be starting trials of the COVID-19 vaccine candidate developed by Oxford University and AstraZeneca by the end of August on up to 5,000 Indian volunteers after getting the necessary nods, and launch the vaccine by June next year if all goes well. The Pune-based company's chief executive Adar Poonawalla said the company, which is the largest vaccine maker in the world, is putting USD 200 million at risk by manufacturing nearly 300 million doses before the final nod to launch the vaccine in market, which is expected at best by the end of the year. If this goes to plan, the phase three trials will take two months after the patients get injected and the vaccine gets a final nod by November, he said, adding that in such a scenario, it can get introduced either in "quarter one or two" of next year. The company has already manufactured around 2-3 million doses of the vaccine for getting the process correct and also stabilising its machinery, Ponnawalla said, clarifying that these will never be used on humans.

India Trials Covid Million Vaccine Oxford Serum Institute Sii  adding  vaccine  begin  doses  trials  augustend  volunteers  covid19  serum  million  institute  oxfords  india  phase  month  company

History of this topic

Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla
4 months, 3 weeks ago

Serum Institute 'hopeful' of producing Mpox vaccine, says CEO Adar Poonawalla

India TV News  

The Serum Institute of India announced on Tuesday that it is actively developing a vaccine for Monkeypox, with positive results anticipated within a year. Serum Institute's vaccine development efforts Serum Institute of India is working on a Monkeypox vaccine to address the global health emergency declared by the WHO. The vaccine is expected to be ready within a year, according …

Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in Africa
6 months ago

Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in Africa

India Today  

A new “high efficacy” malaria vaccine co-developed by the Serum Institute of India and the University of Oxford was officially rolled out on Monday when Cote d’Ivoire in West Africa became the first country to begin administering R21/Matrix-M. In total, 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around …

Milestone in malaria battle as £3 vaccine is rolled out across Africa which could eradicate killer, mosquito-borne illness within 10 years
6 months ago

Milestone in malaria battle as £3 vaccine is rolled out across Africa which could eradicate killer, mosquito-borne illness within 10 years

Daily Mail  

African babies are set to receive a £3 malaria vaccine that could potentially eradicate the disease within a decade. African babies will receive a £3 malaria vaccine that could eradicate malaria within a decade The first doses of the R21 jab, developed by a team at the University of Oxford, will be given to babies under the age of two …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months, 1 week ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
8 months, 1 week ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

Serum Institute of India joins global network to boost production of affordable outbreak vaccines
11 months, 3 weeks ago

Serum Institute of India joins global network to boost production of affordable outbreak vaccines

The Hindu  

The Serum Institute of India will join a growing CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future disease outbreaks. The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions, and take it a step closer to achieving …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

‘Now We Have Two’: WHO Lauds SII, Oxford for Developing Second Malaria Vaccine
1 year, 3 months ago

‘Now We Have Two’: WHO Lauds SII, Oxford for Developing Second Malaria Vaccine

News 18  

The World Health Organisation recommended the R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India for use as it met required safety, quality and effectiveness standards, according to a report by news agency ANI. The vaccine was recommended for use after a rigorous, detailed scientific review by the Strategic Advisory Group of Experts and …

Oxford-Serum institute malaria vaccine recommended for use by WHO
1 year, 3 months ago

Oxford-Serum institute malaria vaccine recommended for use by WHO

The Hindu  

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been recommended for use by the World Health Organisation after meeting required safety, quality and effectiveness standards, on Monday. According to information released by the Serum Institute, the WHO recommendation was based on pre-clinical and clinical trial data which …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 6 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

Serum Institute to double investment in Biocon’s unit to $300 million
1 year, 8 months ago

Serum Institute to double investment in Biocon’s unit to $300 million

Live Mint  

As part of its expansion of investment in one of Biocon Ltd's units, Serum Institute of Life Sciences will give it access to 100 million vaccine doses annually. As per the new alliance, the company would pump in $150 million after converting a loan to Biocon Pharma Limited into equity in Biocon Biologics Ltd. The investment made is in addition …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

Hope for African children as Oxford R21 malaria vaccine is cleared for use in Ghana
1 year, 9 months ago

Hope for African children as Oxford R21 malaria vaccine is cleared for use in Ghana

The Independent  

A new malaria vaccine developed at the University of Oxford that could protect millions of children has been approved for use for the first time, by Ghana. Adrian Hill, director of the University of Oxford’s Jenner Institute at the Nuffield Department of Medicine, said: “Particularly since Covid, African regulators have been taking a much more proactive stance, they’ve been saying.we …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 9 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 11 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
1 year, 11 months ago

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1

News 18  

Over 7,000 doses of the world’s first intranasal Covid-19 vaccine, Bharat Biotech’s iNCOVACC, have been checked and released by the country’s apex vaccine testing laboratory, News18.com has learnt. BBV154, a novel adenovirus vectored intranasal vaccine for Covid-19, was sent to CDL in the first week of January in around six batches containing 15,000 doses. In polio, the dropper drops the …

Private hospitals with advance orders to get intranasal COVID-19 shots soon
1 year, 11 months ago

Private hospitals with advance orders to get intranasal COVID-19 shots soon

The Hindu  

Union Health Minister Mansukh Mandaviya and Minister of Science and Technology Jitendra Singh launched first-of-it’s-kind intranasal COVID-19 vaccine iNCOVACC manufactured by Hyderabad-based Vaccine developer Bharat Biotech International Limited on January 26, 2023. It is the world’s first Intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose, administered as nasal drops. The …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 11 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
1 year, 11 months ago

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26

Hindustan Times  

Bhopal: Bharat Biotech’s nasal Covid-19 vaccine iNCOVACC is expected to be launched on January 26, executive chairman Krishna Ella said at an event on Saturday. “Our nasal vaccine will be officially launched on January 26 on Republic Day,” Ella told students at the Maulana Azad National Institute of Technology in Bhopal, where the India International Science Festival, 2022, is being …

No second Covid-19 booster dose required: Report
2 years ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
2 years ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
2 years ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude
2 years, 1 month ago

Oxford, Serum initiative: Anti-malaria vaccine’s Phase 3 trials conclude

Hindustan Times  

Oxford University and the Serum Institute of India have completed Phase 3 trials for the R21 anti-malarial vaccine in Africa, company officials said on Monday. “Phase-3 trial for R21, which is a cost-effective multi-stage malaria vaccine, is completed in Africa,” said Umesh Shaligram, executive director of Serum Institute of India, on Monday. The makers said that the aim of the …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 3 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla
2 years, 4 months ago

Serum Institute Will Try to Launch Omicron-specific Covid-19 Vaccine After Six Months, Says Adar Poonawalla

News 18  

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday. “The original Novovax vaccine Covovax covers omicron and there is good data for it. We will try to launch Omicron-specific vaccine after six months,” he said. The Pune-based Serum Institute is working with US biotechnology major Novavax …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech
2 years, 5 months ago

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech

Deccan Chronicle  

HYDERABAD: Bharat Biotech International Limited on Monday said its COVID-19 intranasal vaccine has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. Product development related to pre-clinical safety evaluation, large-scale manufacturing scale-up, formulation, and delivery device development, including human clinical trials, was conducted by Bharat Biotech. Suchitra K Ella, Joint Managing Director, Bharat Biotech, …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 5 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry
2 years, 5 months ago

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry

Firstpost  

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain New Delhi: The Ministry of Health and Family Welfare on Sunday informed that more than 7.20 crore balance and unutilized COVID-19 vaccine doses are still available …

Serum institute prepares to import Monkeypox vaccine in India amid global worry
2 years, 5 months ago

Serum institute prepares to import Monkeypox vaccine in India amid global worry

Live Mint  

With India having reported four Monkeypox cases so far, the Serum Institute of India has said that it is negotiating the import of a small of the vaccine with the Danish firm Bavarian Nordic, reported PTI. Quoting SII CEO Adar Poonawalla, the news agency stated in case of a collaboration, it may take two to three months to get the …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt
2 years, 5 months ago

4 Cr Eligible Beneficiaries Havn't Taken Even Single Dose of Covid-19 Vaccine as on July 18: Govt

News 18  

An estimated 4 crore eligible beneficiaries have not taken even a single dose of COVID-19 vaccine as on July 18, Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday. A total of 1,78,38,52,566 vaccine doses have been administered free of cost in Government Covid Vaccination Centres till July 18, she said in a written reply. …

Two billion Covid vaccine doses given in India, government says
2 years, 5 months ago

Two billion Covid vaccine doses given in India, government says

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy India’s health ministry on Sunday …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

India Set to Achieve Milestone of 200 Crore Covid Vaccinations
2 years, 5 months ago

India Set to Achieve Milestone of 200 Crore Covid Vaccinations

News 18  

India is on the brink of administering 200 crore Covid-19 vaccine doses. Before India’s new milestone is achieved in what is being called the “largest vaccine drive” by the central government, union health minister Mansukh Mandaviya tweeted saying history was about to be created under the leadership of Prime Minister Narendra Modi. The countdown to two billion doses began earlier …

COVID-19: India to soon reach 200 crore vaccination mark, says PM Modi
2 years, 6 months ago

COVID-19: India to soon reach 200 crore vaccination mark, says PM Modi

India TV News  

Highlights India is close to administering 200 crore COVID vaccine doses, said PM Modi PM advised people to take necessary precautions like hand hygiene, masks etc. PM Modi also asked people to be alert of diseases caused by surrounding filth during rainy season COVID vaccination news updates : Prime Minister Narendra Modi on Sunday said India is close to administering …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

COVID-19: Nasal vaccine's phase 3 trial completed, informs Bharat Biotech chief
2 years, 6 months ago

COVID-19: Nasal vaccine's phase 3 trial completed, informs Bharat Biotech chief

Firstpost  

Dr Krishna Ella said that the company will submit its data with Drugs Controller General of India next month and If everything is okay, it will be the world’s first clinically proven nasal COVID-19 vaccine Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said that the clinical phase III trials of the COVID-19 nasal vaccine have …

Close to 200 crore Covid vaccine doses administered in India so far: Health ministry
2 years, 6 months ago

Close to 200 crore Covid vaccine doses administered in India so far: Health ministry

India TV News  

Highlights The countrywide vaccination drive was rolled out on January 16 last year Vaccination of frontline workers started from February 2 last year Vaccination for all people aged more than 45 years began on April 1 last year The cumulative COVID-19 vaccine doses administered in the country reached nearly 196 crore on Friday, the Union Health Ministry said. A total …

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad
2 years, 8 months ago

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad

News 18  

India may reduce the gap between the second Covid-19 vaccine shot and the precautionary third dose from nine to six months for citizens who are scheduled to travel abroad, especially to countries that have made it compulsory for travelers to produce their booster certificates. According to the advisory issued by the Union Ministry of Health and Family Welfare, the gap …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 9 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 9 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 9 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Discover Related